More on AQST

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (10.0 Score)
- Holders

Upcoming Events

- Earnings (11/5/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Aquestive Therapeutics Inc. (NQ:AQST)
Delayed: 4.25 +0.02 (0.47%)
Prev. Close $4.23  
Open$4.25 
52 Wk High$ 
52 Wk Low$ 
Day High$4.39 
Day Low$4.14 
P/E N/A  
EPS$ 
Volume3,738,019 

Friends, Peers and Foes (?): TLSA (more...)

Aug 11, 2026 04:12 PM Form 10-Q Aquestive Therapeutics, For: Jun 30
Aug 11, 2026 04:07 PM Form 8-K Aquestive Therapeutics, For: Aug 11
Aug 11, 2026 04:01 PM Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 11, 2026 04:01 PM Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 10, 2026 07:06 AM Form 8-K Aquestive Therapeutics, For: Aug 10
Aug 10, 2026 07:02 AM Aquestive reports study results for Anaphylm ahead of NDA resubmission
Aug 10, 2026 07:00 AM Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm™ (dibutepinephrine) Sublingual Film
Jul 29, 2026 07:00 AM Aquestive Therapeutics to Report Second Quarter 2026 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET
Jul 27, 2026 04:26 PM Form SCHEDULE 13G/A Aquestive Therapeutics, Filed by: BlackRock, Inc.
Jul 17, 2026 01:15 PM Form 4 Aquestive Therapeutics, For: Jul 15 Filed by: Barber Daniel
View All Articles

Entities mentioned with AQST

View All Entities